Synaptic autoimmunity: new insights into LGI1 antibody-mediated neuronal dysfunction.
暂无分享,去创建一个
[1] Arjune Sen,et al. Distinctive binding properties of human monoclonal LGI1 autoantibodies determine pathogenic mechanisms , 2020, Brain : a journal of neurology.
[2] D. Schmitz,et al. Human Cerebrospinal Fluid Monoclonal LGI1 Autoantibodies Increase Neuronal Excitability , 2020, Annals of neurology.
[3] V. Lennon,et al. Neurologic Autoimmunity in the Era of Checkpoint Inhibitor Cancer Immunotherapy. , 2019, Mayo Clinic proceedings.
[4] C. Geis,et al. LGI1 antibodies alter Kv1.1 and AMPA receptors changing synaptic excitability, plasticity and memory , 2018, Brain : a journal of neurology.
[5] H. Shigematsu,et al. Structural basis of epilepsy-related ligand–receptor complex LGI1–ADAM22 , 2018, Nature Communications.
[6] J. Matsumoto,et al. Glycine receptor modulating antibody predicting treatable stiff-person spectrum disorders , 2018, Neurology: Neuroimmunology & Neuroinflammation.
[7] G. Widman,et al. The importance of early immunotherapy in patients with faciobrachial dystonic seizures , 2017, Brain : a journal of neurology.
[8] J. Britton,et al. Expanded phenotypes and outcomes among 256 LGI1/CASPR2‐IgG–positive patients , 2017, Annals of neurology.
[9] Ian C. Clift,et al. Autoantibody-induced internalization of CNS AQP4 water channel and EAAT2 glutamate transporter requires astrocytic Fc receptor , 2017, Proceedings of the National Academy of Sciences.
[10] Masahiko Watanabe,et al. Autoantibodies to Epilepsy-Related LGI1 in Limbic Encephalitis Neutralize LGI1-ADAM22 Interaction and Reduce Synaptic AMPA Receptors , 2013, The Journal of Neuroscience.
[11] A. Vincent,et al. Antibodies to Kv1 potassium channel-complex proteins leucine-rich, glioma inactivated 1 protein and contactin-associated protein-2 in limbic encephalitis, Morvan’s syndrome and acquired neuromyotonia , 2010, Brain : a journal of neurology.